These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1253 related articles for article (PubMed ID: 29372247)

  • 1. Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality.
    Inohara T; Xian Y; Liang L; Matsouaka RA; Saver JL; Smith EE; Schwamm LH; Reeves MJ; Hernandez AF; Bhatt DL; Peterson ED; Fonarow GC
    JAMA; 2018 Feb; 319(5):463-473. PubMed ID: 29372247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics and Outcomes Associated With Oral Anticoagulant Use Among Patients Hospitalized With Intracerebral Hemorrhage.
    Xian Y; Zhang S; Inohara T; Grau-Sepulveda M; Matsouaka RA; Peterson ED; Piccini JP; Smith EE; Sheth KN; Bhatt DL; Fonarow GC; Schwamm LH
    JAMA Netw Open; 2021 Feb; 4(2):e2037438. PubMed ID: 33591368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation.
    Xian Y; O'Brien EC; Liang L; Xu H; Schwamm LH; Fonarow GC; Bhatt DL; Smith EE; Olson DM; Maisch L; Hannah D; Lindholm B; Lytle BL; Pencina MJ; Hernandez AF; Peterson ED
    JAMA; 2017 Mar; 317(10):1057-1067. PubMed ID: 28291892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Recent Use of Non-Vitamin K Antagonist Oral Anticoagulants With Intracranial Hemorrhage Among Patients With Acute Ischemic Stroke Treated With Alteplase.
    Kam W; Holmes DN; Hernandez AF; Saver JL; Fonarow GC; Smith EE; Bhatt DL; Schwamm LH; Reeves MJ; Matsouaka RA; Khan YM; Unverdorben M; Birmingham MC; Lyden PD; Asimos AW; Altschul D; Schoonover TL; Jumaa MA; Nomura JT; Suri MFK; Moore SA; Lafranchise EF; Olson D; Peterson ED; Xian Y
    JAMA; 2022 Feb; 327(8):760-771. PubMed ID: 35143601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K antagonists but not non-vitamin K antagonists in addition on antiplatelet therapy should be associated with increase of hematoma volume and mortality in patients with intracerebral hemorrhage: A sub-analysis of PASTA registry study.
    Nomura K; Suda S; Abe A; Iguchi Y; Yagita Y; Kanzawa T; Okubo S; Fujimoto S; Kimura K;
    J Neurol Sci; 2023 May; 448():120643. PubMed ID: 37028263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intracerebral Hemorrhagic Expansion Occurs in Patients Using Non-Vitamin K Antagonist Oral Anticoagulants Comparable with Patients Using Warfarin.
    Melmed KR; Lyden P; Gellada N; Moheet A
    J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1874-1882. PubMed ID: 28647419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Liao JN; Chung FP; Chen TJ; Lip GYH; Chen SA
    Circulation; 2018 Jul; 138(1):37-47. PubMed ID: 29490992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracerebral Hematoma Occurring During Warfarin Versus Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
    Takahashi H; Jimbo Y; Takano H; Abe H; Sato M; Fujii Y; Aizawa Y
    Am J Cardiol; 2016 Jul; 118(2):222-5. PubMed ID: 27289294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation.
    Lin SY; Chang YC; Lin FJ; Tang SC; Dong YH; Wang CC
    J Am Heart Assoc; 2022 Mar; 11(6):e022849. PubMed ID: 35243876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral hemorrhage associated with warfarin versus non-vitamin K antagonist oral anticoagulants in Asian patients.
    Woo HG; Chung I; Gwak DS; Kim BK; Kang JH; Kim BJ; Bae HJ; Han MK
    J Clin Neurosci; 2019 Mar; 61():160-165. PubMed ID: 30587420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic Treatment and Clinical Outcomes After Intracerebral Hemorrhage: A Retrospective Cohort Study from the Swedish Stroke Register.
    Tallroth M; Udumyan R; Büki A; von Euler M
    J Am Heart Assoc; 2024 May; 13(10):e034716. PubMed ID: 38726922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale.
    Xian Y; Hernandez AF; Harding T; Fonarow GC; Bhatt DL; Suter RE; Khan Y; Schwamm LH; Peterson ED
    Am Heart J; 2016 Dec; 182():28-35. PubMed ID: 27914497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracranial Hemorrhage Caused by Non-Vitamin K Antagonist Oral Anticoagulants (NOACs)- Multicenter Retrospective Cohort Study in Japan.
    Saji N; Kimura K; Aoki J; Uemura J; Sakamoto Y
    Circ J; 2015; 79(5):1018-23. PubMed ID: 25739470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke Who Take Non-Vitamin K Antagonist Oral Anticoagulants Before Stroke.
    Xian Y; Federspiel JJ; Hernandez AF; Laskowitz DT; Schwamm LH; Bhatt DL; Smith EE; Fonarow GC; Peterson ED
    Circulation; 2017 Mar; 135(11):1024-1035. PubMed ID: 28119380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Atrial Fibrillation Patients With Intracerebral Hemorrhage.
    Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GYH; Larsen TB
    Stroke; 2019 Apr; 50(4):939-946. PubMed ID: 30869568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Use of Non-Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation.
    Chang SH; Chou IJ; Yeh YH; Chiou MJ; Wen MS; Kuo CT; See LC; Kuo CF
    JAMA; 2017 Oct; 318(13):1250-1259. PubMed ID: 28973247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet Agents and Oral Anticoagulant Use in Patients with Atrial Fibrillation and Carotid Artery Disease After First-Time Ischaemic Stroke.
    Harrison SL; Buckley BJR; Lane DA; Fazio-Eynullayeva E; Underhill P; Hill A; Werring DJ; Lip GYH
    Cardiovasc Drugs Ther; 2024 Aug; 38(4):731-737. PubMed ID: 36692658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of Bleeding Following Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Acute Ischemic Stroke Treated With Alteplase.
    Tsai TY; Liu YC; Huang WT; Tu YK; Qiu SQ; Noor S; Huang YC; Chou EH; Lai EC; Huang HK
    JAMA Intern Med; 2024 Jan; 184(1):37-45. PubMed ID: 37983035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.